Lassonde Industries Inc (LAS-A)
Toronto Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 246.41 |
|---|---|
| 52-week range | 202.51 – 253.85 |
| Return, 1 month / 3 months | +0.2% / +17.4% |
| Return, 1 year / 3 years | +17.3% / +107.9% |
| Trend | Uptrend |
| RSI (14) | 60 |
| Volatility (1 year) | 34.0% |
| Worst drawdown (1 year) | -19.1% |
| Average daily value traded | 0.44M CAD |
| Dividend yield | 2.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Lassonde Industries Inc is a Canadian beverage and food company based in Quebec. It makes fruit juices, juice blends and other drinks, along with specialty food products such as sauces and fondue broths. Its brands include Oasis and Allen's, and it supplies grocery stores and food service customers, mainly in Canada and the United States, through its own labels and private-label production for retailers.
The shares are listed on the Toronto Exchange in Canada under the code LAS-A, and the price on this page is in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Lassonde Industries Inc (LAS-A) trades on the Toronto Exchange in Canada. It last closed at CAD 246.41 on 23 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 209 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 17.3% and over the last three months it rose 17.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 78 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 9.4% | ||
| From 52-week high | -1.8% | ||
| Momentum | 71 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 17.4% | ||
| 6-month return | 8.4% | ||
| 12-month return, skipping the last month | 17.1% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.1% | ||
| Liquidity | 43 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.44M CAD | ||
| Zero-volume days | 1.7% | ||
| Income | 52 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.0% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.0% |
|---|---|
| 1 month | +0.2% |
| 3 months | +17.4% |
| 6 months | +8.4% |
| 1 year | +17.3% |
| 3 years | +107.9% |
| 5 years | +56.4% |
Signals
| 50-day / 200-day average | 238.68 / 225.28 |
|---|---|
| Golden / death cross (60 days) | Golden, 41 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.16 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 Aug 2026 | CAD 1.2500 |
| 20 May 2026 | CAD 1.2500 |
| 20 Feb 2026 | CAD 1.2500 |
| 19 Nov 2025 | CAD 1.1000 |
| 19 Aug 2025 | CAD 1.1000 |
| 21 May 2025 | CAD 1.1000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.